As Conatus Pharmaceuticals (CNAT) Market Value Rose, Mpm Asset Management Has Lifted Its Position by $3.64 Million; As Proto Labs (PRLB) Market Valuation Rose, Mairs & Power Has Cut Its Stake

April 18, 2018 - By Hazel Jackson

Proto Labs, Inc. (NYSE:PRLB) Logo

Mpm Asset Management Llc increased its stake in Conatus Pharmaceuticals Inc. (CNAT) by 76.26% based on its latest 2017Q4 regulatory filing with the SEC. Mpm Asset Management Llc bought 909,091 shares as the company’s stock rose 13.83% while stock markets declined. The institutional investor held 2.10 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $9.71 million, up from 1.19 million at the end of the previous reported quarter. Mpm Asset Management Llc who had been investing in Conatus Pharmaceuticals Inc. for a number of months, seems to be bullish on the $112.73M market cap company. The stock increased 1.08% or $0.04 during the last trading session, reaching $3.75. About 555,423 shares traded. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has risen 12.92% since April 18, 2017 and is uptrending. It has outperformed by 1.37% the S&P500.

Mairs & Power Inc decreased its stake in Proto Labs (PRLB) by 21.82% based on its latest 2017Q4 regulatory filing with the SEC. Mairs & Power Inc sold 107,550 shares as the company’s stock rose 19.21% while stock markets declined. The institutional investor held 385,402 shares of the capital goods company at the end of 2017Q4, valued at $39.70M, down from 492,952 at the end of the previous reported quarter. Mairs & Power Inc who had been investing in Proto Labs for a number of months, seems to be less bullish one the $3.42 billion market cap company. The stock increased 5.00% or $6.05 during the last trading session, reaching $127.05. About 193,411 shares traded or 11.53% up from the average. Proto Labs, Inc. (NYSE:PRLB) has risen 143.95% since April 18, 2017 and is uptrending. It has outperformed by 132.40% the S&P500.

Analysts await Proto Labs, Inc. (NYSE:PRLB) to report earnings on April, 26 before the open. They expect $0.62 earnings per share, up 34.78% or $0.16 from last year’s $0.46 per share. PRLB’s profit will be $16.70 million for 51.23 P/E if the $0.62 EPS becomes a reality. After $0.53 actual earnings per share reported by Proto Labs, Inc. for the previous quarter, Wall Street now forecasts 16.98% EPS growth.

Mairs & Power Inc, which manages about $7.72 billion and $8.62B US Long portfolio, upped its stake in Lilly (Eli) (NYSE:LLY) by 37,532 shares to 1.01M shares, valued at $85.68 million in 2017Q4, according to the filing. It also increased its holding in Physicians Realty Tr (NYSE:DOC) by 18,000 shares in the quarter, for a total of 926,610 shares, and has risen its stake in Gentherm Inc (NASDAQ:THRM).

Since December 11, 2017, it had 0 buys, and 5 selling transactions for $981,678 activity. On Monday, February 12 the insider Bodor Robert sold $200,455. 1,114 shares valued at $136,700 were sold by Goodman John B on Wednesday, March 14. Gawlick Rainer sold $51,375 worth of stock or 500 shares.

Investors sentiment increased to 1.42 in Q4 2017. Its up 0.15, from 1.27 in 2017Q3. It improved, as 17 investors sold PRLB shares while 57 reduced holdings. 40 funds opened positions while 65 raised stakes. 25.09 million shares or 3.57% less from 26.02 million shares in 2017Q3 were reported. Wealthtrust reported 381 shares or 0.02% of all its holdings. Riverbridge Prtnrs Ltd Co reported 3.54% of its portfolio in Proto Labs, Inc. (NYSE:PRLB). Tiverton Asset Management Llc owns 65,294 shares. Tiaa Cref Invest Ltd Liability Company holds 0% in Proto Labs, Inc. (NYSE:PRLB) or 61,019 shares. 643,829 were reported by State Common Retirement Fund. Swiss Financial Bank holds 0% of its portfolio in Proto Labs, Inc. (NYSE:PRLB) for 42,500 shares. Evercore Wealth Mngmt Limited Liability Corp accumulated 65 shares. California State Teachers Retirement System invested 0.01% of its portfolio in Proto Labs, Inc. (NYSE:PRLB). First Mercantile Trust Company holds 0.08% of its portfolio in Proto Labs, Inc. (NYSE:PRLB) for 4,081 shares. Advisory Limited Com accumulated 40 shares. 51,331 are owned by Legal General Group Inc Public Limited Com. Maverick Ltd reported 67,732 shares. The Connecticut-based Aqr Cap Mngmt Ltd Limited Liability Company has invested 0% in Proto Labs, Inc. (NYSE:PRLB). Royal Bancorp Of Canada owns 265,130 shares. Employees Retirement Systems Of Texas owns 27,000 shares.

Among 8 analysts covering Proto Labs (NYSE:PRLB), 3 have Buy rating, 0 Sell and 5 Hold. Therefore 38% are positive. Proto Labs had 15 analyst reports since August 26, 2015 according to SRatingsIntel. The firm has “Sell” rating by Dougherty & Company given on Wednesday, August 31. The stock has “Neutral” rating by Dougherty & Company on Tuesday, June 27. Piper Jaffray maintained Proto Labs, Inc. (NYSE:PRLB) on Wednesday, December 13 with “Hold” rating. The firm earned “Outperform” rating on Wednesday, May 11 by FBR Capital. The rating was maintained by Dougherty & Company on Friday, April 28 with “Sell”. The rating was maintained by Piper Jaffray with “Hold” on Thursday, July 27. The stock has “Outperform” rating by Oppenheimer on Wednesday, August 26. The firm has “Buy” rating by Canaccord Genuity given on Thursday, October 15. The stock has “Hold” rating by Craig Hallum on Monday, November 27. The rating was maintained by Piper Jaffray with “Hold” on Thursday, October 26.

Proto Labs, Inc. (NYSE:PRLB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: